- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02444780
Observational Study on Plasma Glutamine Levels Before and After Cardiac Surgery
February 16, 2016 updated by: Matty Koopmans, Medical Centre Leeuwarden
Earlier studies showed that a low glutamine level at acute admission on the ICU is associated with a poor outcome [3,4].
Recently, we found that a low plasma glutamine is correlated with severity of illness and presence of an infection after non-elective ICU admission [5, submitted].
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
It is known that major surgery induces a stress response characterised by hormonal release and inflammatory processes [6,7].
This surgical stress response resembles the catabolic stress which is found in other forms of critical illness.
We did not measure plasma glutamine before surgery so it is unknown whether the plasma glutamine level was already low before surgery in these patients or that the lowering of plasma glutamine level is a consequence of surgery.
Most of the patients in the elective surgery group in our study underwent cardiac surgery with use of cardiopulmonary bypass; it is known that extracorporeal circulation induces an inflammatory response but there are no clinical data on the effects on plasma glutamine or on post-operative course in relation to plasma glutamine levels [8,9].
Study Type
Observational
Enrollment (Actual)
90
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All consecutive patients who undergo elective cardio-thoracic surgery during a 6 to 8 week period.
We aim to include at least 90 patients.
Description
Inclusion Criteria:
- patients undergoing elective cardiac surgery
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
elective cardiac surgery patients
consecutive patients who undergo elective cardio-thoracic surgery during a 6 to 8 week period
|
no intervention, blood sampled for standard evaluation will be used for determination of plasma glutamin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
plasma glutamine
Time Frame: intraoperative
|
intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hanneke Buter, MD, MCL
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
May 12, 2015
First Submitted That Met QC Criteria
May 13, 2015
First Posted (Estimate)
May 14, 2015
Study Record Updates
Last Update Posted (Estimate)
February 17, 2016
Last Update Submitted That Met QC Criteria
February 16, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- nWMO 115
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glutamin Level
-
Universiteit AntwerpenCompletedCholesterol Level | HDL Level | LDL Level | TG LevelBelgium
-
Karabuk UniversityCompletedHemoglobin Level Measurement | Hemoglobin Level EstimationTurkey
-
Retropsoas Technologies, LLCNot yet recruitingUndergoing a Single-level or Two-level TLIF SurgeryUnited States
-
Assiut UniversityNot yet recruitingIsoagglutinins Level
-
Ayşegül AkcaThe Scientific and Technological Research Council of TurkeyCompleted
-
Necmettin Erbakan UniversityCompletedInternet | Stress LevelTurkey
-
TCI Co., Ltd.Completed
-
National Taiwan University HospitalCompleted
Clinical Trials on no intervention, blood is sampled for routine
-
University College, LondonUniversity College London HospitalsCompletedQuality of Life | Precancerous Conditions | Patient Engagement | Patient Participation | Oral Disease | Patient Satisfaction | Health Behavior | Precancerous Lesions | Oral Leukoplakia | Dental Diseases | Oral Lichen Planus | Dysplasia | Patient Preference | Information Seeking Behavior | Oral Epithelial Dysplasia | Oral... and other conditionsUnited Kingdom
-
University of VirginiaCompletedCancer | Motivation | Smoking BehaviorsUnited States
-
Children's Hospital of PhiladelphiaNational Highway Traffic Safety Administration (NHTSA); Laerdal MedicalCompleted
-
Alexandria UniversityRecruitingMyalgic EncephalomyelitisEgypt
-
Göteborg UniversityTerminatedSepsis | Septic Shock | SIRS | Sepsis, Severe | Post-Op ComplicationSweden
-
GenesisCare USATerminated
-
University of Dublin, Trinity CollegeCompleted
-
The University of Texas Health Science Center,...CompletedWound InfectionUnited States
-
Chinese University of Hong KongCompleted
-
Washington University School of MedicineCompletedPulmonary Disease, Chronic ObstructiveUnited States